Therabot results graphic (IMAGE)
Caption
Study participants on average experienced statistically significant improvements in their symptoms after using Therabot for eight weeks. The trial consisted of 106 people from across the United States diagnosed with major depressive disorder, generalized anxiety disorder, or an eating disorder. Some users had more than one diagnosis. Almost 75% of Therabot users in the study were not under any other treatment at the time.
Credit
LaDarius Dennison/Dartmouth
Usage Restrictions
N/A
License
Original content